Study the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric Varices
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
To observe the Safety and Efficacy of Compont Medical Glue in the Treatment of Esophagogastric Varices.
Condition or disease
Esophageal and Gastric Varices
"Compont Medical Glue" is a kind of histoacryl producted by Compont Company. It has been used to treat esophagogastric varices for several years. This study is a prospective multicenter,open study on the safety and efficacy of Compont Medical Glue in the treatment of esophagogastric varices. Weather the patient receiving injection of Compont Medical Glue is according to the degree of esophageal-gastric varices and is decided by the experienced endoscopic physicians. No additional intervention will be given to the patients, no matter whether patients are participated in the study.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with esophagogastric varices caused by portal hypertension who might need to receive endoscopy treatment.
Esophagogastric varices caused by portal hypertension with or without history of bleeding and no matter whether emergency bleeding.
Patients may need to receive injection of histoacryl.
Have signed informed consent.
Allergic to formaldehyde or cyanoacrylate.
Women who are pregnant or breast-feeding.
With contraindications of endoscopic exam.
Computed tomography(CT)/Computed tomography angiography(CTA) shows that patient with severe portosystemic shunt.
Large amount of blood accumulated in the stomach severely affects the endoscopic vision clarity.
Other reasons that researcher think the patient is unsuitable for participating in the study.